Biotech · Private company · Seattle, WA, US
Lumen Bioscience, Inc.
Track this companyFree. Adds Lumen Bioscience, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- LMN-201Phase 3 · Clostridioides Difficile InfectionClinicalTrials.gov · fetched Nov 12, 2026
- LMN-101Phase 2 · Campylobacter InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- LMN-201 for Prevention of C. Difficile Infection RecurrencePHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Aug 29, 2024ClinicalTrials.gov NCT05330182 · fetched Nov 12, 2026
- LMN-101 in a Campylobacter Human Challenge ModelPHASE2 · COMPLETED · started Feb 21, 2022ClinicalTrials.gov NCT04182490 · fetched Nov 12, 2026
NIH awards1
- Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.Fiscal year 2024 · $925.3KNIH RePORTER 5R42AI138623-05 · fetched Nov 12, 2026